Concepedia

Brian L. Wiens

BL

Statistics

Publications

35

Citations

7K

H-Index

24

Active since

1992

Affiliations

Amgen (United States)(Current)

United States Military Academy

IQVIA (United States)

Eli Lilly (United States)

Gilead Sciences (United States)

Brian L. Wiens is an author at Amgen (United States) specializing in medicine, pharmacology, and biostatistics.

ORCID

Publications per year

1992–2017

35

Publications

35

Ambrisentan for the Treatment of Pulmonary Arterial Hypertension

Nazzareno Galiè, Horst Olschewski, Ronald J. Oudiz et al. · Circulation · 2008 · 1.1K citations

, , +16

Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity

Deborah Siegal, John T. Curnutte, Stuart J. Connolly et al. · New England Journal of Medicine · 2015 · 1K citations · Full text

, , +17

Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors

Truman J. Milling, John W. Eikelboom, C. Michael Gibson et al. · New England Journal of Medicine · 2016 · 787 citations · Full text

, , +10

A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis

Scott L. Friedman, Vlad Ratziu, Stephen A. Harrison et al. · Hepatology · 2017 · 658 citations · Full text

, , +17

A Controlled Trial of a Formalin-Inactivated Hepatitis A Vaccine in Healthy Children

Alan Werzberger, Barbara Mensch, Barbara J. Kuter et al. · New England Journal of Medicine · 1992 · 541 citations · Full text

, , +13

1–5 of 35